Kwang Dong Pharmaceutical Co., Ltd. (KRX:009290)

Kwang Dong Pharmaceutical Revenue

Kwang Dong Pharmaceutical had revenue of 410.85B KRW in the quarter ending March 31, 2026, with 8.81% growth. This brings the company's revenue in the last twelve months to 1.69T, up 5.41% year-over-year. In the year 2025, Kwang Dong Pharmaceutical had annual revenue of 1.66T with 1.15% growth.

• Revenue (ttm): 1.69T
• Revenue Growth: +5.41%
• P/S Ratio: 0.14
• Revenue / Employee: 1.66B
• Employees: 1,021
• Market Cap: 230.59B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.66T	18.79B	1.15%
Dec 31, 2024	1.64T	126.26B	8.34%
Dec 31, 2023	1.51T	82.91B	5.79%
Dec 31, 2022	1.43T	93.36B	6.98%
Dec 31, 2021	1.34T	94.41B	7.59%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 14, 2026

Data Sources Report a data error